MedPath

Gloperba

These highlights do not include all the information needed to use GLOPERBA safely and effectively. See full prescribing information for GLOPERBA. GLOPERBA (colchicine) Oral Solution Initial U.S. Approval: 1961

Approved
Approval ID

467cd83f-d695-4040-9434-10e80b4271da

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 28, 2023

Manufacturers
FDA

Scilex Pharmaceuticals, Inc.

DUNS: 078286225

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Colchicine

PRODUCT DETAILS

NDC Product Code69557-222
Application NumberNDA210942
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateAugust 1, 2022
Generic NameColchicine

INGREDIENTS (11)

ColchicineActive
Quantity: 0.6 mg in 5 mL
Code: SML2Y3J35T
Classification: ACTIB
benzyl alcoholInactive
Code: LKG8494WBH
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT
sucraloseInactive
Code: 96K6UQ3ZD4
Classification: IACT
xanthan gumInactive
Code: TTV12P4NEE
Classification: IACT
FD&C Red No. 40Inactive
Code: WZB9127XOA
Classification: IACT
anhydrous citric acidInactive
Code: XF417D3PSL
Classification: IACT
SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORMInactive
Code: GR686LBA74
Classification: IACT
glycerinInactive
Code: PDC6A3C0OX
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
CherryInactive
Code: BUC5I9595W
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Gloperba - FDA Drug Approval Details